Moreover, RBM5 suppression also triggered notable myeloid differentiation in AML cells, as demonstrated by the increased expression of myeloid maturation markers CD11b and CD14 in both mRNA and protein levels, together with morphologic features of differentiation (Fig. 3d; Additional file 1: Fig. S3a, b). This evidence concerns the gene ITGAM and acute myeloid leukemia.